Search the Newsreel

Deutsche Bank Adjusts Aveanna Healthcare PT to $16 From $11.50, Maintains Buy Rating

Deutsche Bank has increased its price target for Aveanna Healthcare Holdings Inc. (AVAH) to $16 from $11.50, while reiterating a Buy rating on the stock. This adjustment reflects an updated outlook from the bank regarding the company's valuation. Earlier the same day, UBS also …

Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial

Fractyl Health is anticipating key data in Q4 for its Revita treatment, an endoscopic procedure aimed at preventing weight regain after GLP-1 assisted weight loss. The company is also launching a clinical trial for Rejuva, a gene therapy designed to induce pancreatic beta cells …

Numans Health Food Signals Higher Profit on Lower Revenue in Supplemental Alert

China Tian Yuan Healthcare Schedules Board Meeting on Interim Results and Dividend

Cosmos Health Inc expected to post earnings of 1 cent a share - Earnings Preview

Cosmos Health Inc is anticipated to report earnings of 1 cent per share. This article provides an earnings preview for the company. Access to the full Reuters article is available through a TradingView subscription.

Raymond James raises Aveanna Healthcare stock price target on strong results

Raymond James raised its price target on Aveanna Healthcare Holdings (NASDAQ:AVAH) to $15.00 from $13.00, maintaining a Strong Buy rating due to strong Q2 2026 results and an increased EBITDA guidance. The company also reported Q2 2026 revenue of $670.5 million, exceeding analyst forecasts, …

Distinct Healthcare Holdings (SEHK:2677) Stock Looks Cheap Until One Off Gains Fade

China Healthwise Sets August Board Meeting to Review Interim Results and Dividend

Fortis Healthcare shares gain 2.52%, trades at Rs 929.00

Primary Health Properties (LON:PHP) Price Target Raised to GBX 133

Should I Buy GUTS (Fractyl Health, Inc. Common Stock) | AI Analysis, Technical & News Insights

Sinohealth Technology Sets Board Meeting to Review Interim Results and Consider Dividend

Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings?

Sotera Health Company (SHC) has gained 11.3% over the last six months, slightly underperforming the S&P 500. Analysts are not recommending SHC due to slow organic growth, limited distribution channels for a small company in a scale-dependent industry, and breakeven free cash flow constraining …

Wedge Capital Management L L P NC Acquires 222,447 Shares of Ardent Health, Inc. $ARDT

Wedge Capital Management L L P NC significantly increased its stake in Ardent Health, Inc. (NYSE:ARDT) during the second quarter, purchasing an additional 222,447 shares to bring its total ownership to 327,242 shares valued at approximately $3.22 million. Other institutional investors also expanded their …

The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From Clover Health's Q2 Earnings Call Clover Health's second quarter results were met with a positive market reaction, driven by strong Medicare Advantage membership growth and improved profitability. Management credited the quarter's performance to the expansion of its …

Here’s How Much You Would Have Made Owning Molina Healthcare Stock In The Last 15 Years

Molina Healthcare (NYSE: MOH) has outperformed the market over the past 15 years, achieving an average annual return of 17.74%. An investment of $1000 in MOH stock 15 years ago would now be worth $11,447.41, demonstrating the significant impact of compounded returns on cash …

Smart Fish Wealthlink Sets Board Meeting to Review Interim Results and Dividend

AGL|agilon health inc|Price:89.299|Chg%:+3.039

OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Hold" by Analysts

OPKO Health, Inc. (NASDAQ:OPK) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $1.55. Recent analyst actions include upgrades from Weiss Ratings and Wall Street Zen, a downgrade from Barrington Research, and a reissued "buy" rating from HC …

HCA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving HCA Healthcare, Inc.

Kirby McInerney LLP is investigating potential claims against HCA Healthcare, Inc. (NYSE:HCA) following a significant drop in its stock price. The investigation stems from HCA Healthcare's lowered 2026 profit guidance, which cited an unfavorable shift in payer mix and an increase in uninsured patients, …

Assenagon Asset Management S.A. Makes New Investment in HealthEquity, Inc. $HQY

Assenagon Asset Management S.A. has initiated a new position in HealthEquity, Inc. (NASDAQ:HQY) by purchasing 21,215 shares valued at approximately $1.9 million. This investment comes as HealthEquity exceeded its quarterly earnings expectations with $1.24 EPS and revenue of $354.64 million, representing a 7.2% year-over-year …

DaVita (DVA) Stock Looks Discounted On Earnings While Returns Look Strong

Bank of America Corp DE Boosts Stake in Healthcare Realty Trust Incorporated $HR

AVAH|Aveanna Healthcare Holdings Inc|Price:12.320|Chg%:+1.030

Astrana Health (ASTH) Is Up 10.7% After Raising 2026 Guidance And Doubling Q2 Net Income - Has The Bull Case Changed?

Austco Healthcare (ASX:AHC) Builds Recurring Revenue Path Through US Hospital Expansion

Zota Health's Davaindia Network crosses 2,825 stores as revenue jumps 68% in Q1 FY27

MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record Sequential Growth and Strategic De-Risking

MDxHealth SA (MDXH) achieved its largest quarter-over-quarter revenue acceleration in Q2 2026, increasing 14% sequentially, while eliminating a $10.4 million liability. The company strengthened its balance sheet with a $20 million financing and reaffirmed its full-year 2026 revenue guidance of $110 million to $115 …

Aveanna stock hits 52-week high after Q2 beat (AVAH:NASDAQ)

Aveanna hits 52-week high after Q2 beat, guidance hike

[Close up image of wooden cubes with alphabet Q2 on office desk.] mohd izzuan Shares of Aveanna Healthcare (AVAH [https://seekingalpha.com/symbol/AVAH]) reached a new 52-week high on Thursday after the home healthcare provider reported better-than-expected Q2 2026 financials and raised its full-year outlook above the …

Max Healthcare Institute shares fall 2.47% to Rs 988.30

5 Must-Read Analyst Questions From Elanco’s Q2 Earnings Call

5 Must-Read Analyst Questions From Elanco's Q2 Earnings Call Elanco's results for the second quarter were positively received by the market, reflecting momentum across both its Pet Health and Farm Animal businesses. Management attributed growth to strong execution in the U.S. and international markets, …

Guardant Health Sees Shield, MRD and Oncology Testing Growth Accelerate

Guardant Health reported accelerated growth in its oncology testing, minimal residual disease (MRD), and colorectal cancer screening businesses, with significant year-over-year increases in revenue for Guardant360 and Guardant Reveal. The company plans to launch its tumor-informed Reveal Ultra test in 2026 and expects a …

AMN Healthcare (AMN) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Randle ReecePresident and Chief Executive Officer - Caroline GraceChief Financial and Operating Officer - Brian Scott TAKEAWAYS Revenue -- $673 million, representing …

Is Tenet Healthcare (THC) Overvalued Following Higher 2026 Adjusted EPS Guidance?

Tenet Healthcare (THC) has seen a significant surge in its share price and an increase in its 2026 adjusted EPS guidance, leading to questions about its valuation. While some analysts deem it overvalued at $250 compared to its last close of $267.05, others note …

Apotex Health (TSX:APTX) Stock Hit By Revenue Drop And Profit Reversal